Services

Allergenix will conduct preclinical trials on a contract research basis and may license its technology to third parties interested in performing their own in-house research. Suitable partners are also sought with expertise in drug discovery to collaborate in the identification of novel targets.

Allergenix Pty Ltd offers its expertise in inflammatory diseases and the use of its proprietary sheep model of allergy and human asthma for:

• Preclinical studies to validate new drug targets.
• Evaluation of drug delivery technologies.
• Target discovery using innovative approaches and high throughput technologies.